Paper17547475
Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
Tytgat GN. Drugs, 2007. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Papers, record 17547475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547475
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Butylscopolammonium Bromide | Major topic |
| Colic | Major topic |
| Animals | |
| Clinical Trials as Topic | |
| Humans | |
| Molecular Structure | |
| Muscarinic Antagonists | |
| Parasympatholytics | |
| Treatment Outcome |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10896640 | Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. | Ann Intern Med | 2000 | https://conductscience.org/library/papers/10896640 | PubMed |
| 2 | 16842469 | Prevalence and management of abdominal cramping and pain: a multinational survey. | Aliment Pharmacol Ther | 2006 | https://conductscience.org/library/papers/16842469 | PubMed |
| 3 | 16817918 | Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. | Aliment Pharmacol Ther | 2006 | https://conductscience.org/library/papers/16817918 | PubMed |
| 4 | 4390607 | The actions of atropine, tropenziline and N-butyl hyoscine bromide on the isolated distal colon of the guinea-pig: a comparison of their activities and mechanisms of action. | J Pharm Pharmacol | 1969 | https://conductscience.org/library/papers/4390607 | PubMed |
| 5 | 15606387 | Meta-analysis: The treatment of irritable bowel syndrome. | Aliment Pharmacol Ther | 2004 | https://conductscience.org/library/papers/15606387 | PubMed |
| 6 | 12425586 | Systematic review on the management of irritable bowel syndrome in North America. | Am J Gastroenterol | 2002 | https://conductscience.org/library/papers/12425586 | PubMed |
| 7 | 16445300 | Costs of irritable bowel syndrome in the UK and US. | Pharmacoeconomics | 2006 | https://conductscience.org/library/papers/16445300 | PubMed |
| 8 | 328327 | A double-blind comparative study of the inhibitory effect of intraduodenally administered hyoscine-N-butylbromide on human duodenal motility. | J Int Med Res | 1977 | https://conductscience.org/library/papers/328327 | PubMed |
| 9 | 4679187 | [Effect of rectally applied hyoscin-N-butylbromide on small intestine motility]. | Arzneimittelforschung | 1972 | https://conductscience.org/library/papers/4679187 | PubMed |
| 10 | 6147311 | Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog. | Int J Clin Pharmacol Ther Toxicol | 1984 | https://conductscience.org/library/papers/6147311 | PubMed |
| 11 | 15256832 | Quality of life and illness costs in irritable bowel syndrome. | Digestion | 2004 | https://conductscience.org/library/papers/15256832 | PubMed |
| 12 | 4885158 | [Testing of orally administered spasmolytics demonstrated by the effect of hyoscine-N-butylbromide on gastric motility]. | Arzneimittelforschung | 1968 | https://conductscience.org/library/papers/4885158 | PubMed |
| 13 | 15862938 | Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work. | Gastroenterol Clin North Am | 2005 | https://conductscience.org/library/papers/15862938 | PubMed |
| 14 | 10877233 | Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. | Dig Dis Sci | 2000 | https://conductscience.org/library/papers/10877233 | PubMed |
| 15 | 15243388 | Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. | Gastroenterol Clin Biol | 2004 | https://conductscience.org/library/papers/15243388 | PubMed |
| 16 | 6526796 | Different therapeutic regimens in irritable bowel syndrome. | J Assoc Physicians India | 1984 | https://conductscience.org/library/papers/6526796 | PubMed |
| 17 | 11207510 | Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. | Aliment Pharmacol Ther | 2001 | https://conductscience.org/library/papers/11207510 | PubMed |
| 18 | 32949 | Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. | Br Med J | 1979 | https://conductscience.org/library/papers/32949 | PubMed |
| 19 | 7284686 | Oral hyoscine butylbromide does not alter the pattern of small intestinal motor activity. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/7284686 | PubMed |
| 20 | 5820047 | [Inhibition of small intestine motility by orally administered hyoscine-N-butylbromide]. | Arzneimittelforschung | 1969 | https://conductscience.org/library/papers/5820047 | PubMed |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42952977 | Hyoscine N-butylbromide administration before colostrum feeding improves passive transfer in dairy calves. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42952977 | PubMed |
| 42773320 | Pharmacotherapy of Irritable Bowel Syndrome with Constipation in Children: An Update on Clinical Progress and Successes. | Drugs | 2026 | https://conductscience.org/library/papers/42773320 | PubMed |
| 41866875 | Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome. | Turk J Gastroenterol | 2025 | https://conductscience.org/library/papers/41866875 | PubMed |
| 41482625 | A real-world study to describe the effectiveness and usage patterns of hyoscine butylbromide plus tablets in patients with dysmenorrhoea. | Womens Health (Lond) | 2026 | https://conductscience.org/library/papers/41482625 | PubMed |
| 41257808 | Holistic approach to dysmenorrhea management: Integrating pharmacological and non-pharmacological interventions for improved women's health in the Middle East and Africa. | BMC Womens Health | 2025 | https://conductscience.org/library/papers/41257808 | PubMed |
| 41155589 | Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-b]thiazole-Derivatives from Calcium Entry Blockers to a New Approach for Gut Dysfunctional Motility. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155589 | PubMed |
| 40839003 | Antispasmodic activity of a series of cyclic imides (phthalimides) derivatives. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/40839003 | PubMed |
| 40655474 | Efficacy of herbal medicine (Thatbunjob) in the treatment of foodborne illness: A placebo-controlled, randomized trial. | Integr Med Res | 2025 | https://conductscience.org/library/papers/40655474 | PubMed |
| 40371460 | Acid/Base-Responsive Circularly Polarized Luminescence Emitters with Configurationally Stable Nitrogen Stereogenic Centers. | Adv Mater | 2025 | https://conductscience.org/library/papers/40371460 | PubMed |
| 40364041 | A Comprehensive Review of the Effects of Hyoscine Butylbromide in Childhood. | J Clin Med | 2025 | https://conductscience.org/library/papers/40364041 | PubMed |
| 40331189 | Effect of propinox and pinaverium bromide on ex vivo colonic motor patterns and their synergistic effect with hyoscine butyl bromide. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40331189 | PubMed |
| 40308456 | Anticholinergic agents and impaired cognitive function: is there a risk for patients with irritable bowel syndrome? | Ther Adv Gastroenterol | 2025 | https://conductscience.org/library/papers/40308456 | PubMed |
| 40303371 | Real-world effects of hyoscine butylbromide combined with paracetamol in women with dysmenorrhea: a patient survey. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40303371 | PubMed |
| 39875349 | Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease. | Gut Microbes | 2025 | https://conductscience.org/library/papers/39875349 | PubMed |
| 39473756 | Hyoscine-n-butylbromide in treating abdominal pain caused by gastroenteritis: a double-blind randomized placebo-controlled study. | Turk J Med Sci | 2024 | https://conductscience.org/library/papers/39473756 | PubMed |
| 39199604 | Antispasmodic Agents in Magnetic Resonance Imaging of the Urinary Bladder-A Narrative Review. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199604 | PubMed |
| 39042346 | Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/39042346 | PubMed |
| 38188926 | Provider-reported use of butylscopolamine in gastrointestinal endoscopy in Germany. | Endosc Int Open | 2024 | https://conductscience.org/library/papers/38188926 | PubMed |
| 37576742 | Comparative evaluation of the potential anti-spasmodic activity of Piper longum, Piper nigrum, Terminalia bellerica, Terminalia chebula, and Zingiber officinale in experimental animals. | Saudi Pharm J | 2023 | https://conductscience.org/library/papers/37576742 | PubMed |
| 37171269 | Assessment of T2-weighted Image Quality at Prostate MRI in Patients with and Those without Intramuscular Injection of Glucagon. | Radiol Imaging Cancer | 2023 | https://conductscience.org/library/papers/37171269 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17547475
GET https://conductscience.org/api/papers/v1/17547475/references?page=2